These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Epidemiological characteristics of Acinetobacter baumannii infections at Phramongkutklao Hospital. Aimsaad L; Diraphat P; Utrarachkij F; Thunyaharn S; Samakoses R; Siripanichgon K J Med Assoc Thai; 2009 Dec; 92 Suppl 7():S164-72. PubMed ID: 20232569 [TBL] [Abstract][Full Text] [Related]
45. Efficacy of tigecycline for secondary Acinetobacter bacteremia and factors associated with treatment failure. Liou BH; Lee YT; Kuo SC; Liu PY; Fung CP Antimicrob Agents Chemother; 2015; 59(6):3637-40. PubMed ID: 25824230 [TBL] [Abstract][Full Text] [Related]
46. Impact of rapid identification of Acinetobacter Baumannii via matrix-assisted laser desorption ionization time-of-flight mass spectrometry combined with antimicrobial stewardship in patients with pneumonia and/or bacteremia. Wenzler E; Goff DA; Mangino JE; Reed EE; Wehr A; Bauer KA Diagn Microbiol Infect Dis; 2016 Jan; 84(1):63-68. PubMed ID: 26603136 [TBL] [Abstract][Full Text] [Related]
47. Acquisition and clearance of multidrug resistant Acinetobacter baumannii on healthy young adults concurrently burned in a dust explosion in Taiwan: the implication for antimicrobial stewardship. Huang PY; Shie SS; Ye JJ; Lin SP; Liu TP; Wu TS; Wu TL; Chuang SS; Cheng MH; Hsieh YC; Huang CT BMC Infect Dis; 2017 Aug; 17(1):598. PubMed ID: 28854887 [TBL] [Abstract][Full Text] [Related]
48. A case-control study to identify predictors of 14-day mortality following carbapenem-resistant Acinetobacter baumannii bacteraemia. Nutman A; Glick R; Temkin E; Hoshen M; Edgar R; Braun T; Carmeli Y Clin Microbiol Infect; 2014 Dec; 20(12):O1028-34. PubMed ID: 24930471 [TBL] [Abstract][Full Text] [Related]
49. Molecular Epidemiology and Drug Resistance of Acinetobacter baumannii Isolated from Hospitals in Southern Poland: ICU as a Risk Factor for XDR Strains. Chmielarczyk A; Pilarczyk-Żurek M; Kamińska W; Pobiega M; Romaniszyn D; Ziółkowski G; Wójkowska-Mach J; Bulanda M Microb Drug Resist; 2016 Jun; 22(4):328-35. PubMed ID: 26745326 [TBL] [Abstract][Full Text] [Related]
51. Investigation of carbapenem-resistant Acinetobacter baumannii isolates in a district hospital in Taiwan. Chen CM; Liu PY; Ke SC; Wu HJ; Wu LT Diagn Microbiol Infect Dis; 2009 Apr; 63(4):394-7. PubMed ID: 19302926 [TBL] [Abstract][Full Text] [Related]
52. A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii. Sheng WH; Liao CH; Lauderdale TL; Ko WC; Chen YS; Liu JW; Lau YJ; Wang LH; Liu KS; Tsai TY; Lin SY; Hsu MS; Hsu LY; Chang SC Int J Infect Dis; 2010 Sep; 14(9):e764-9. PubMed ID: 20646946 [TBL] [Abstract][Full Text] [Related]
53. Carbapenem-resistant Acinetobacter baumannii mediastinitis after aortic graft implantation successfully treated by adjunctive gentian violet irrigation and antibiotic combination therapy. Li SJ; Chang CW; Chen FL; Ou TY; Lee WS J Microbiol Immunol Infect; 2016 Dec; 49(6):977-979. PubMed ID: 27553449 [No Abstract] [Full Text] [Related]
54. Emergence of carbapenem resistance in Acinetobacter baumannii recovered from blood cultures in Australia. Peleg AY; Franklin C; Bell JM; Spelman DW Infect Control Hosp Epidemiol; 2006 Jul; 27(7):759-61. PubMed ID: 16807854 [TBL] [Abstract][Full Text] [Related]
56. Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United States. Wisplinghoff H; Paulus T; Lugenheim M; Stefanik D; Higgins PG; Edmond MB; Wenzel RP; Seifert H J Infect; 2012 Mar; 64(3):282-90. PubMed ID: 22209744 [TBL] [Abstract][Full Text] [Related]
57. Control of hospital endemicity of multiple-drug-resistant Acinetobacter baumannii ST457 with directly observed hand hygiene. Cheng VC; Chen JH; Poon RW; Lee WM; So SY; Wong SC; Chau PH; Yip CC; Wong SS; Chan JF; Hung IF; Ho PL; Yuen KY Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):713-8. PubMed ID: 25413926 [TBL] [Abstract][Full Text] [Related]
58. Impact of reduced tigecycline susceptibility on clinical outcomes of Acinetobacter bacteremia. Chang YY; Liu YM; Liu CP; Kuo SC; Chen TL; J Microbiol Immunol Infect; 2018 Feb; 51(1):148-152. PubMed ID: 29050749 [TBL] [Abstract][Full Text] [Related]
59. High prevalence of oxacillinases in clinical multidrug-resistant Acinetobacter baumannii isolates from the Tshwane region, South Africa - an update. Lowings M; Ehlers MM; Dreyer AW; Kock MM BMC Infect Dis; 2015 Nov; 15():521. PubMed ID: 26573617 [TBL] [Abstract][Full Text] [Related]
60. Identification of multidrug- and carbapenem-resistant Acinetobacter baumannii in Canada: results from CANWARD 2007. McCracken M; DeCorby M; Fuller J; Loo V; Hoban DJ; Zhanel GG; Mulvey MR J Antimicrob Chemother; 2009 Sep; 64(3):552-5. PubMed ID: 19578083 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]